FILING ANALYSIS · TUESDAY, NOVEMBER 3
Alamar Biosciences, Inc. ALMR — 8-K: Results of Operations and Financial Condition
positive
Alamar Biosciences reported a 68% increase in revenue for the third quarter of 2026 and raised its full-year revenue guidance to $121-123 million, representing 64% growth at the midpoint. The company also announced the retirement of its president, Tod White, effective December 31, 2026.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →